经鼻、眶上与经眶入路:前颅窝与中颅窝脑膜瘤的微创内镜辅助手术入路
该连续病例系列纳入2007至2022年接受内镜经鼻入路(EEA)、眶上入路(SOA)或经眶入路(TOA)切除新诊断前颅窝与中颅窝脑膜瘤的88例患者,比较各入路的目标区域、肿瘤体积分布、全切除率及并发症。结果显示SOA组肿瘤体积最大,总体全切除率84%,TOA组全切除率50%且归因于蝶眶脑膜瘤(33%),术后脑脊液漏7例(8%)。
要点
- EEA用于蝶骨平台与鞍结节脑膜瘤(n=44),SOA用于嗅沟与前床突脑膜瘤(n=36),TOA用于蝶眶与中颅窝脑膜瘤(n=8)。
- SOA组肿瘤体积最大(平均28±29 cm³),TOA组10±10 cm³,EEA组9±8 cm³(p=0.024)。
- 总体全切除率84%(n=74),EEA 84%、SOA 92%、TOA 50%(p=0.002),TOA低全切除率归因于蝶眶脑膜瘤(33%)而非中颅窝脑膜瘤(100%)。
核心结论
- 前颅窝与中颅窝颅底脑膜瘤的微创入路需仔细选择病例,除蝶眶脑膜瘤外各入路全切除率均较高,蝶眶脑膜瘤手术主要目标是缓解突眼而非全切除。
- EEA术后新发嗅觉丧失最常见。
研究设计与样本
- 2007至2022年连续病例系列,纳入新诊断前颅窝与中颅窝颅底脑膜瘤接受EEA、SOA或TOA的88例患者(占525例脑膜瘤切除术的16.7%)。
- 制作概率热图展示各入路肿瘤体积分布,评估全切除、切除范围、视觉与嗅觉结局及术后并发症。
主要发现
- EEA用于蝶骨平台与鞍结节脑膜瘤(n=44),SOA用于嗅沟与前床突脑膜瘤(n=36),TOA用于蝶眶与中颅窝脑膜瘤(n=8)。
- SOA组肿瘤体积最大(平均28±29 cm³),TOA组10±10 cm³,EEA组9±8 cm³(p=0.024)。
- 91%病例为WHO I级;总体全切除率84%(n=74),EEA 84%、SOA 92%、TOA 50%(p=0.002),TOA低全切除率归因于蝶眶脑膜瘤(33%)而非中颅窝脑膜瘤(100%)。
- 脑脊液漏7例(8%):EEA 5例(11%)、SOA 1例(3%)、TOA 1例(13%)(p=0.326),除1例EEA漏需再手术外均经腰大池引流缓解。
- EEA术后新发嗅觉丧失最常见。
临床怎么用
- 作者认为微创入路用于前颅窝与中颅窝颅底脑膜瘤需仔细选择病例。
- 作者认为蝶眶脑膜瘤手术主要目标是缓解突眼而非全切除。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Minimally invasive endoscope-assisted approaches to the anterior skull base offer an alternative to traditional open craniotomies. Given the restrictive operative corridor, appropriate case selection is critical for success. In this paper, the authors present the results of three different minimal access approaches to meningiomas of the anterior and middle fossae and examine the differences in the target areas considered appropriate for each approach, as well as the outcomes, to determine whether the surgical goals were achieved. METHODS: A consecutive series of the endoscopic endonasal approach (EEA), supraorbital approach (SOA), or transorbital approach (TOA) for newly diagnosed meningiomas of the anterior and middle fossa skull base between 2007 and 2022 were examined. Probabilistic heat maps were created to display the distribution of tumor volumes for each approach. Gross-total resection (GTR), extent of resection, visual and olfactory outcomes, and postoperative complications were assessed. RESULTS: Of 525 patients who had meningioma resection, 88 (16.7%) were included in this study. EEA was performed for planum sphenoidale and tuberculum sellae meningiomas (n = 44), SOA for olfactory groove and anterior clinoid meningiomas (n = 36), and TOA for spheno-orbital and middle fossa meningiomas (n = 8). The largest tumors were treated using SOA (mean volume 28 ± 29 cm3), followed by TOA (mean volume 10 ± 10 cm3) and EEA (mean volume 9 ± 8 cm3) (p = 0.024). Most cases (91%) were WHO grade I. GTR was achieved in 84% of patients (n = 74), which was similar to the rates for EEA (84%) and SOA (92%), but lower than that for TOA (50%) (p = 0.002), the latter attributable to spheno-orbital (GTR: 33%) not middle fossa (GTR: 100%) tumors. There were 7 (8%) CSF leaks: 5 (11%) from EEA, 1 (3%) from SOA, and 1 (13%) from TOA (p = 0.326). All resolved with lumbar drainage except for 1 EEA leak that required a reoperation. CONCLUSIONS: Minimally invasive approaches for anterior and middle fossa skull base meningiomas require careful case selection. GTR rates are equally high for all approaches except for spheno-orbital meningiomas, where alleviation of proptosis and not GTR is the primary goal of surgery. New anosmia was most common after EEA.
引用
- Carnevale JA, Pandey A, Ramirez-Loera C, et al. Endonasal, supraorbital, and transorbital approaches: minimal access endoscope-assisted surgical approaches for meningiomas in the anterior and middle cranial fossae. J Neurosurg. 2023. PMID: 37410637. doi:10.3171/2023.5.JNS23103
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。